| Ranked All-Publication list | Historiographs | Glossary HistCite Guide About |
| Nodes: 72, Authors: 339, Journals: 29, Cited References: 2229, Words: 324
Yearly output | Document Type | Language | Institution | Institution with Subdivision | Country |
| View: Overview | Sorted by LCS. |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 0 | 51 | 19 2005 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 102 (26): 9294-9299 Zhong J; Gastaminza P; Cheng GF; Kapadia S; Kato T; et al. Robust hepatitis C virus infection in vitro | 71 | 71 |
| 2 | 1 | 100 | 12 2005 NATURE 436 (7053): 933-938 Lindenbach BD; Rice CM Unravelling hepatitis C virus replication from genome to function | 8 | 15 |
| 3 | 1 | 32 | 16 2005 NATURE 437 (7062): 1167-1172 Meylan E; Curran J; Hofmann K; Moradpour D; Binder M; et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus | 7 | 41 |
| 4 | 1 | 50 | 55 2006 JOURNAL OF VIROLOGY 80 (4): 1734-1741 Tscherne DM; Jones CT; Evans MJ; Lindenbach BD; McKeating JA; et al. Time-and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry | 4 | 4 |
| 5 | 1 | 39 | 11 2005 NATURE 436 (7053): 930-932 Chisari FV Unscrambling hepatitis C virus-host interactions | 3 | 9 |
| 6 | 1 | 94 | 13 2005 NATURE 436 (7053): 939-945 Gale M; Foy EM Evasion of intracellular host defence by hepatitis C virus | 3 | 19 |
| 7 | 1 | 91 | 15 2005 NATURE 436 (7053): 967-972 Feld JJ; Hoofnagle JH Mechanism of action of interferon and ribavirin in treatment of hepatitis C | 3 | 15 |
| 8 | 1 | 13 | 20 2005 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 102 (28): 9739-9740 Bartenschlager R; Pietschmann T Efficient hepatitis C virus cell culture system: What a difference the host cell makes | 3 | 3 |
| 9 | 2 | 66 | 42 2006 JOURNAL OF BIOLOGICAL CHEMISTRY 281 (7): 3909-3917 Lavillette D; Bartosch B; Nourrisson D; Verney G; Cosset FL; et al. Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes | 3 | 3 |
| 10 | 1 | 81 | 8 2005 JOURNAL OF VIROLOGY 79 (21): 13594-13605 Quinkert D; Bartenschlager R; Lohmann V Quantitative analysis of the hepatitis C virus replication complex | 2 | 4 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 11 | 1 | 44 | 9 2005 JOURNAL OF VIROLOGY 79 (22): 13963-13973 Cai ZH; Zhang C; Chang KS; Jiang JY; Ahn BC; et al. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells | 2 | 2 |
| 12 | 3 | 27 | 69 2006 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (10): 3805-3809 Lindenbach BD; Meuleman P; Ploss A; Vanwolleghem T; Syder AJ; et al. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro | 2 | 2 |
| 13 | 5 | 72 | 2 2005 HEPATOLOGY 42 (6): 1264-1269 Berke JM; Moradpour D Hepatitis C virus comes full circle: Production of recombinant infectious virus in tissue culture | 1 | 2 |
| 14 | 1 | 34 | 4 2005 JOURNAL OF CLINICAL MICROBIOLOGY 43 (11): 5679-5684 Kato T; Date T; Miyamoto M; Sugiyama M; Tanaka Y; et al. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system | 1 | 1 |
| 15 | 1 | 55 | 6 2005 JOURNAL OF GENERAL VIROLOGY 86: 3189-3199 Sandrin V; Boulanger P; Penin F; Granier C; Cosset FL; et al. Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins | 1 | 2 |
| 16 | 1 | 64 | 7 2005 JOURNAL OF IMMUNOLOGY 175 (12): 8226-8235 Lee SH; Kim YK; Kim CS; Seol SK; Kim J; et al. E2 of hepatitis C virus inhibits apoptosis | 1 | 2 |
| 17 | 1 | 72 | 14 2005 NATURE 436 (7053): 961-966 Houghton M; Abrignani S Prospects for a vaccine against the hepatitis C virus | 1 | 6 |
| 18 | 1 | 68 | 23 2005 TRENDS IN MICROBIOLOGY 13 (11): 528-534 Seeger C Salient molecular features of hepatitis C virus revealed | 1 | 1 |
| 19 | 1 | 46 | 39 2006 HEPATOLOGY 43 (5): 932-942 von Hahn T; Lindenbach BD; Boullier A; Quehenberger O; Paulson M; et al. Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells | 1 | 1 |
| 20 | 1 | 44 | 57 2006 JOURNAL OF VIROLOGY 80 (6): 2832-2841 Rouille Y; Helle F; Delgrange D; Roingeard P; Voisset U; et al. Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus | 1 | 1 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 21 | 4 | 29 | 67 2006 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (7): 2310-2315 Yi M; Villanueva RA; Thomas DL; Wakita T; Lemon SM Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells | 1 | 1 |
| 22 | 4 | 29 | 70 2006 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (15): 6001-6006 Loo YM; Owen DM; Li K; Erickson AK; Johnson CL; et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection | 1 | 1 |
| 23 | 1 | 10 | 1 2005 CHEMISTRY & INDUSTRY (18): 22-24 Strosberg D; Burnet M The molecular approach | 0 | 0 |
| 24 | 1 | 59 | 3 2005 JOURNAL OF BIOLOGICAL CHEMISTRY 280 (48): 39802-39808 Domitrovich AM; Felmlee DJ; Siddiqui A Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion | 0 | 0 |
| 25 | 1 | 20 | 5 2005 JOURNAL OF GENERAL VIROLOGY 86: 3075-3080 Targett-Adams P; McLauchlan J Development and characterization of a transient-replication assay for the genotype 2a hepatitis C virus subgenomic replicon | 0 | 0 |
| 26 | 1 | 46 | 10 2005 JOURNAL OF VIROLOGY 79 (24): 15525-15536 Griffin S; Clarke D; McCormick C; Rowlands D; Harris M Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes | 0 | 0 |
| 27 | 1 | 11 | 17 2005 NATURE MEDICINE 11 (9): 929-930 Benedict CA; Ware CF RIGing a virus trap | 0 | 0 |
| 28 | 1 | 3 | 18 2005 NATURE METHODS 2 (8): 565-565 Eisenstein M Virology - Home-grown HCV | 0 | 0 |
| 29 | 2 | 22 | 21 2005 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 102 (49): 17539-17540 Freundt EC; Lenardo MJ Interfering with interferons: Hepatitis C virus counters innate immunity | 0 | 2 |
| 30 | 1 | 6 | 22 2005 SCIENTIST 19 (17): 29-30 Jonietz E How does your virus grow? | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 31 | 2 | 53 | 24 2006 AMERICAN JOURNAL OF PATHOLOGY 169 (1): 200-208 Lai WK; Sun PJ; Zhang J; Jennings A; Lalor PF; et al. Expression of DC-SIGN and DC-SIGNR on human sinusoidal endothelium - A role for capturing hepatitis C virus particles | 0 | 0 |
| 32 | 1 | 50 | 25 2006 ANALYTICAL BIOCHEMISTRY 350 (2): 239-248 Tonary AM; Pezacki JP Simultaneous quantitative measurement of luciferase reporter activity and cell number in two-and three-dimensional cultures of hepatitis C virus replicons | 0 | 0 |
| 33 | 1 | 49 | 26 2006 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 50 (3): 1013-1020 Malcolm BA; Liu R; Lahser F; Agrawal S; Belanger B; et al. SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells | 0 | 0 |
| 34 | 2 | 49 | 27 2006 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 50 (5): 1813-1822 Lin K; Perni RB; Kwong AD; Lin C VX-950, a novel hepatitis C virus (HCV) NS34A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells | 0 | 0 |
| 35 | 5 | 196 | 28 2006 ANTIVIRAL RESEARCH 69 (3): 129-141 Thimme R; Lohmann V; Weber F A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus | 0 | 0 |
| 36 | 1 | 221 | 29 2006 ANTIVIRAL THERAPY 11 (3): 273-287 Trepanier JB; Tanner JE; Alfieri C Oligonucleotide-based therapeutic options against hepatitis C virus infection | 0 | 0 |
| 37 | 1 | 36 | 30 2006 CURRENT OPINION IN GASTROENTEROLOGY 22 (3): 193-197 Moseley RH Liver and biliary tract disorders | 0 | 0 |
| 38 | 4 | 18 | 31 2006 EMBO REPORTS 7 (1): 14-17 Rinaldi A The phantom menace | 0 | 0 |
| 39 | 1 | 55 | 32 2006 EUROPEAN JOURNAL OF IMMUNOLOGY 36 (4): 919-929 Crotta S; Ronconi V; Ulivieri C; Baldari CT; Valiente NM; et al. Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cells | 0 | 0 |
| 40 | 1 | 42 | 33 2006 FASEB JOURNAL 20 (2) Maillard P; Huby T; Andreo U; Moreau M; Chapman J; et al. The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 41 | 4 | 97 | 34 2006 GENE THERAPY 13 (6): 563-575 Grimm D; Kay MA Therapeutic short hairpin RNA expression in the liver: viral targets and vectors | 0 | 0 |
| 42 | 1 | 105 | 35 2006 HEPATOLOGY 43 (2): S207-S220 Pawlotsky JM Therapy of hepatitis C: From empiricism to eradication | 0 | 0 |
| 43 | 1 | 48 | 36 2006 HEPATOLOGY 43 (3): 592-601 Tarr AW; Owsianka AM; Timms JM; McClure CP; Brown RJP; et al. Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33 | 0 | 0 |
| 44 | 1 | 46 | 37 2006 HEPATOLOGY 43 (4): 761-770 Paeshuyse J; Kaul A; De Clercq E; Rosenwirth B; Dumont JM; et al. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro | 0 | 0 |
| 45 | 4 | 27 | 38 2006 HEPATOLOGY 43 (5): 903-905 Dreux M; Cosset FL HCV and lipoproteins: Is oxLDL an Achilles' heel of the Trojan horse? | 0 | 0 |
| 46 | 2 | 68 | 40 2006 HEPATOLOGY 43 (6): 1326-1336 Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; et al. Host cell responses induced by hepatitis C virus binding | 0 | 0 |
| 47 | 2 | 26 | 41 2006 HEPATOLOGY 44 (1): 117-125 Ikeda M; Abe K; Yamada M; Dansako H; Naka K; et al. Different anti-HCV profiles of statins and their potential for combination therapy with interferon | 0 | 0 |
| 48 | 2 | 63 | 43 2006 JOURNAL OF BIOLOGICAL CHEMISTRY 281 (15): 9833-9836 Appel N; Schaller T; Penin F; Bartenschlager R From structure to function: New insights into hepatitis C virus RNA replication | 0 | 0 |
| 49 | 2 | 78 | 44 2006 JOURNAL OF BIOLOGICAL CHEMISTRY 281 (27): 18285-18295 Dreux M; Pietschmann T; Granier C; Voisset C; Ricard-Blum S; et al. High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI | 0 | 0 |
| 50 | 1 | 31 | 45 2006 JOURNAL OF GENERAL VIROLOGY 87: 323-327 Liu SH; Ansari IH; Das SC; Pattnaik AK Insertion and deletion analyses identify regions of non-structural protein 5A of Hepatitis C virus that are dispensable for viral genome replication | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 51 | 1 | 35 | 46 2006 JOURNAL OF GENERAL VIROLOGY 87: 861-871 Chapel C; Garcia C; Roingeard P; Zitzmann N; Dubuisson J; et al. Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles | 0 | 0 |
| 52 | 1 | 94 | 47 2006 JOURNAL OF GENERAL VIROLOGY 87: 1075-1084 Cocquerel L; Voisset C; Dubuisson J Hepatitis C virus entry: potential receptors and their biological functions | 0 | 0 |
| 53 | 1 | 57 | 48 2006 JOURNAL OF HEPATOLOGY 44 (2): 411-421 McHutchison JG; Bartenschlager R; Patel K; Pawlotsky JM The face of future hepatitis C antiviral drug development: Recent biological and virologic advances and their translation to drug development and clinical practice | 0 | 1 |
| 54 | 2 | 14 | 49 2006 JOURNAL OF HEPATOLOGY 44 (2): 436-439 Zeisel MB; Baumert TF Production of infectious hepatitis C virus in tissue culture: A breakthrough for basic and applied research | 0 | 0 |
| 55 | 1 | 75 | 50 2006 JOURNAL OF MEDICINAL CHEMISTRY 49 (5): 1693-1705 Koch U; Attenni B; Malancona S; Colarusso S; Conte I; et al. 2-(2-thienyl)-5,6-dihydroxy-4-carboxypyrimidines as inhibitors of the hepatitis C virus NS5B polymerase: Discovery, SAR, modeling, and mutagenesis | 0 | 0 |
| 56 | 1 | 33 | 51 2006 JOURNAL OF VIROLOGICAL METHODS 132 (1-2): 195-203 Hiasa Y; Blackard JT; Lin WY; Kamegaya Y; Horiike N; et al. Cell-based models of sustained, interferon-sensitive hepatitis C virus genotype 1 replication | 0 | 1 |
| 57 | 1 | 55 | 52 2006 JOURNAL OF VIROLOGY 80 (1): 149-160 Paeshuyse J; Leyssen P; Mabery E; Boddeker N; Vrancken R; et al. A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase | 0 | 1 |
| 58 | 1 | 37 | 53 2006 JOURNAL OF VIROLOGY 80 (1): 404-411 Lam AMI; Frick DN Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase | 0 | 0 |
| 59 | 1 | 33 | 54 2006 JOURNAL OF VIROLOGY 80 (3): 1181-1190 Nelson HB; Tang HL Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression | 0 | 1 |
| 60 | 1 | 51 | 56 2006 JOURNAL OF VIROLOGY 80 (4): 1817-1825 Kobayashi M; Bennett MC; Bercot T; Singh IR Functional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 61 | 2 | 72 | 58 2006 JOURNAL OF VIROLOGY 80 (7): 3332-3340 Shimakami T; Honda M; Kusakawa T; Murata T; Shimotohno K; et al. Effect of hepatitis C virus (HCV) NS5B-nucleolin interaction on HCV replication with HCV subgenomic replicon | 0 | 0 |
| 62 | 2 | 34 | 59 2006 JOURNAL OF VIROLOGY 80 (9): 4510-4520 Ishii N; Watashi K; Hishiki T; Goto K; Inoue D; et al. Diverse effects of cyclosporine on hepatitis C virus strain replication | 0 | 0 |
| 63 | 3 | 33 | 60 2006 JOURNAL OF VIROLOGY 80 (9): 4633-4639 Kanda T; Basu A; Steele R; Wakita T; Ryerse JS; et al. Generation of infectious hepatitis C virus in immortalized human hepatocytes | 0 | 0 |
| 64 | 1 | 47 | 61 2006 JOURNAL OF VIROLOGY 80 (10): 4940-4948 Bertaux C; Dragic T Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry | 0 | 0 |
| 65 | 2 | 56 | 62 2006 JOURNAL OF VIROLOGY 80 (11): 5308-5320 Koutsoudakis G; Kaul A; Steinmann E; Kallis S; Lohmann V; et al. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses | 0 | 0 |
| 66 | 4 | 59 | 63 2006 JOURNAL OF VIROLOGY 80 (14): 6964-6972 Blanchard E; Belouzard S; Goueslain L; Wakita T; Dubuisson J; et al. Hepatitis C virus entry depends on clathrin-mediated endocytosis | 0 | 0 |
| 67 | 2 | 98 | 64 2006 MOLECULAR CELL 22 (5): 561-569 Meylan E; Tschopp J Toll-like receptors and RNA helicases: Two parallel ways to trigger antiviral responses | 0 | 0 |
| 68 | 1 | 77 | 65 2006 NUCLEIC ACIDS RESEARCH 34 (9): 2618-2633 Ivanyi-Nagy R; Kanevsky I; Gabus C; Lavergne JP; Ficheux D; et al. Analysis of hepatitis C virus RNA dimerization and core-RNA interactions | 0 | 0 |
| 69 | 2 | 66 | 66 2006 ONCOGENE 25 (27): 3857-3865 Romano PR; McCallus DE; Pachuk CJ RNA interference-mediated prevention and therapy for hepatocellular carcinoma | 0 | 0 |
| 70 | 3 | 23 | 68 2006 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (10): 3500-3501 Bukh J; Purcell RH A milestone for hepatitis C virus research: A virus generated in cell culture is fully viable in vivo | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 71 | 3 | 35 | 71 2006 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (19): 7408-7413 Pietschmann T; Kaul A; Koutsoudakis G; Shavinskaya A; Kallis S; et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras | 0 | 0 |
| 72 | 3 | 28 | 72 2006 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (22): 8499-8504 Cheng G; Zhong J; Chisari FV Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms | 0 | 0 |
Generated by HistCite 2006.08.02